NCT05139875View on ClinicalTrials.gov

Comparing Intra-articular Betamethasone (Diprospan) and Triamcinolone Acetonide Injection in Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Knee Osteoarthritis
Interventions
DRUG

Betamethasone Dipropionate / Betamethasone Sodium Phosphate

Single intra-articular Betamethasone Dipropionate / Betamethasone Sodium Phosphate (Diprospan) injections to affected knee

DRUG

Triamcinolone Acetonide 40mg/mL

Single intra-articular Triamcinolone Acetonide injections to affected knee

Trial Locations (1)

12120

Thammasat University Hospital, Khlong Luang

All Listed Sponsors
lead

Thammasat University

OTHER

NCT05139875 - Comparing Intra-articular Betamethasone (Diprospan) and Triamcinolone Acetonide Injection in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter